These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9857616

  • 1. [Susceptibility of clinical strains of gram-positive bacteria to selected beta-lactam antibiotics].
    Sawicka-Grzelak A, Rokosz A.
    Med Dosw Mikrobiol; 1998; 50(1-2):69-76. PubMed ID: 9857616
    [Abstract] [Full Text] [Related]

  • 2. [Susceptibility of clinical strains of gram-negative rods to selected beta-lactam antibiotics].
    Rokosz A, Sawicka-Grzelak A.
    Med Dosw Mikrobiol; 1997; 49(3-4):191-8. PubMed ID: 9554152
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Kapil A.
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R, Duval J.
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [Abstract] [Full Text] [Related]

  • 9. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK, Mendes RE, Silbert S, Bolsoni AP, Sader HS.
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [Abstract] [Full Text] [Related]

  • 10. [Comparative activity of meropenem and other antibiotics against the pathogens of nosocomial infections].
    Sidorenko SV, Rezvan SP, Grudinina SA, Sterkhova GV, Aleksandrova IA.
    Antibiot Khimioter; 1998 Oct; 43(1):4-14. PubMed ID: 9532326
    [Abstract] [Full Text] [Related]

  • 11. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
    Nomura S, Hanaki H, Nagayama A.
    J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
    Appelbaum PC, Spangler SK, Jacobs MR.
    J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
    [Abstract] [Full Text] [Related]

  • 13. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK, Ying CM, Lee CC, Liu ZK.
    Med Princ Pract; 2005 Aug; 14(5):338-41. PubMed ID: 16103700
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of in vitro susceptibility of hospital bacterial isolates to piperacillin and tazocin (piperacillin/tazobactam].
    Birawska I, Fuchs J, Szulakowska E.
    Med Dosw Mikrobiol; 1998 Aug; 50(1-2):41-6. PubMed ID: 9857612
    [Abstract] [Full Text] [Related]

  • 15. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods].
    Rokosz A, Sawicka-Grzelak A, Kot K, Pituch H, Meisel-Mikołajczyk F, Luczak M.
    Med Dosw Mikrobiol; 2000 Aug; 52(2):129-37. PubMed ID: 11107787
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L, Sposini T, Bartoli A, Marconi P.
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [Abstract] [Full Text] [Related]

  • 18. [Characteristic of clinical strains of gram-negative obligate anaerobes].
    Kadzielska J, Kierzkowska M, Sawicka-Grzelak A, Rokosz A, Łuczak M.
    Med Dosw Mikrobiol; 2007 Apr; 59(4):351-7. PubMed ID: 18416127
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R, Mittermayer H, Feierl G, Allerberger F, Wendelin I, Hirschl A, Reisinger EC.
    Wien Klin Wochenschr; 1999 Jul 30; 111(14):549-54. PubMed ID: 10467641
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.